← Open Payments lookup

MICHELLE GRIMES: Open Payments

NPI 1578881082 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,365 in 40 payments from 10 companies in 2025. Trend: 2023 $1,036 · 2024 $1,142 · 2025 $1,365

Food & beverage: $1,365
CompanyPaymentsAmount
GENZYME CORPORATION13$382
Regeneron Healthcare Solutions, Inc.9$290
AstraZeneca Pharmaceuticals LP3$209
AERIN MEDICAL INC.3$188
Optinose US, Inc.6$146
GlaxoSmithKline, LLC.2$51
Smith+Nephew, Inc.1$38
Merck Sharp & Dohme LLC1$25
Integra LifeSciences Corporation1$18
Hikma Pharmaceuticals USA1$17

Products named: DUPIXENT, VIVAER STYLUS, Xhance, TEZSPIRE, NUCALA, KEYTRUDA QLEX, Integra, Ryaltris.

Industry payments across TX — which companies pay providers there.